Literature DB >> 8799510

Tissue reaction to Dacron velour and titanium fibre mesh used for anchorage of percutaneous devices.

Y C Paquay1, J E de Ruijter, J P van der Waerden, J A Jansen.   

Abstract

Dacron velour is often used to anchor a percutaneous device, like the catheter used in peritoneal dialysis. However, exit-site infections complicate this method of dialysis and are supposed to be related to the design of the catheter. In animal experiments, a percutaneous device provided with a titanium fibre mesh to anchor the implant was not affected by infectious complications. The purpose of this study was to compare the differences in soft tissue reaction to Dacron velour and titanium fibre mesh under the same experimental conditions. Therefore, we placed implants, provided with either Dacron or titanium mesh, subcutaneously in the dorsum of goats. The implants were left in situ for 4 months. Histological and histomorphological evaluations were performed. It was found that the soft tissue response inside the Dacron was mainly inflammatory, while the titanium mesh evoked good biocompatible behaviour. We concluded that the limited fibrous tissue ingrowth into the Dacron cuff has to be the reason for the observed high failure incidence of a percutaneous device.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8799510     DOI: 10.1016/0142-9612(96)84946-5

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  10 in total

1.  Tissue reactions to polyethylene implants with different surface topography.

Authors:  A Rosengren; L M Bjursten; N Danielsen; H Persson; M Kober
Journal:  J Mater Sci Mater Med       Date:  1999-02       Impact factor: 3.896

2.  On the formation of fibrous capsule and fluid space around machined and porous blood plasma clot coated titanium.

Authors:  E Jansson; M Källtorp; A Johansson; P Tengvall; P Thomsen
Journal:  J Mater Sci Mater Med       Date:  2001 Oct-Dec       Impact factor: 3.896

3.  A new titanium fiber mesh-cuffed peritoneal dialysis catheter: an experimental animal study.

Authors:  J A Jansen; X F Walboomers
Journal:  J Mater Sci Mater Med       Date:  2001 Oct-Dec       Impact factor: 3.896

4.  Evaluation of the tissue reaction to a percutaneous access device using titanium fibre mesh anchorage in goats.

Authors:  M Gerritsen; Y G Paquay; J A Jansen
Journal:  J Mater Sci Mater Med       Date:  1998-09       Impact factor: 3.896

5.  Pig dorsum model for examining impaired wound healing at the skin-implant interface of percutaneous devices.

Authors:  Brian Mueller Holt; Daniel Holod Betz; Taylor Ann Ford; James Peter Beck; Roy Drake Bloebaum; Sujee Jeyapalina
Journal:  J Mater Sci Mater Med       Date:  2013-07-06       Impact factor: 3.896

6.  Fibered electrolytically detachable platinum coils used for the endovascular treatment of intracranial aneurysms. Initial experiences and mid-term results in 474 aneurysms.

Authors:  T Liebig; H Henkes; S Fischer; W Weber; E Miloslavski; W Mariushi; S Brew; D Kühne
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

7.  Percutaneous implants with porous titanium dermal barriers: an in vivo evaluation of infection risk.

Authors:  Dorthyann Isackson; Lawrence D McGill; Kent N Bachus
Journal:  Med Eng Phys       Date:  2010-12-10       Impact factor: 2.242

8.  The influence of bone formation on anchoring percutaneous devices with titanium fibre mesh flanges.

Authors:  M M Shalabi; X F Walboomers; J A Jansen
Journal:  J Mater Sci Mater Med       Date:  2004-07       Impact factor: 3.896

9.  Viscoelastic response of human skin to low magnitude physiologically relevant shear.

Authors:  Brian Holt; Anubhav Tripathi; Jeffrey Morgan
Journal:  J Biomech       Date:  2008-07-30       Impact factor: 2.712

10.  Long Term Retention of Gingival Sealing around Titanium Implants with CaCl2 Hydrothermal Treatment: A Rodent Study.

Authors:  Yasunori Ayukawa; Wakana Oshiro; Ikiru Atsuta; Akihiro Furuhashi; Ryosuke Kondo; Yohei Jinno; Kiyoshi Koyano
Journal:  J Clin Med       Date:  2019-09-29       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.